Twist Bioscience (TWST) Competitors

Twist Bioscience (NASDAQ:TWST) and Dr. Reddy's Laboratories (NYSE:RDY) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their community ranking, valuation, risk, institutional ownership, analyst recommendations, earnings, profitability, media sentiment and dividends.

Does the media prefer TWST or RDY?

In the previous week, Dr. Reddy's Laboratories had 6 more articles in the media than Twist Bioscience. MarketBeat recorded 8 mentions for Dr. Reddy's Laboratories and 2 mentions for Twist Bioscience. Twist Bioscience's average media sentiment score of 1.65 beat Dr. Reddy's Laboratories' score of -0.04 indicating that Twist Bioscience is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Twist Bioscience	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Dr. Reddy's Laboratories	3 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	2 Very Negative mention(s)	Neutral

Do insiders & institutionals believe in TWST or RDY?

3.9% of Dr. Reddy's Laboratories shares are held by institutional investors. 3.0% of Twist Bioscience shares are held by insiders. Comparatively, 2.0% of Dr. Reddy's Laboratories shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Is TWST or RDY more profitable?

Dr. Reddy's Laboratories has a net margin of 17.25% compared to Twist Bioscience's net margin of -59.76%. Dr. Reddy's Laboratories' return on equity of 17.87% beat Twist Bioscience's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Twist Bioscience	-59.76%	-32.69%	-25.25%
Dr. Reddy's Laboratories	17.25%	17.87%	12.32%

Which has more risk and volatility, TWST or RDY?

Twist Bioscience has a beta of 1.87, suggesting that its stock price is 87% more volatile than the S&P 500. Comparatively, Dr. Reddy's Laboratories has a beta of 0.5, suggesting that its stock price is 50% less volatile than the S&P 500.

Do analysts rate TWST or RDY?

Twist Bioscience presently has a consensus target price of $53.80, suggesting a potential upside of 23.61%. Dr. Reddy's Laboratories has a consensus target price of $17.00, suggesting a potential upside of 27.68%. Given Dr. Reddy's Laboratories' higher probable upside, analysts clearly believe Dr. Reddy's Laboratories is more favorable than Twist Bioscience.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Twist Bioscience	1 Sell rating(s)	1 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.70
Dr. Reddy's Laboratories	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50

Which has better earnings and valuation, TWST or RDY?

Dr. Reddy's Laboratories has higher revenue and earnings than Twist Bioscience. Twist Bioscience is trading at a lower price-to-earnings ratio than Dr. Reddy's Laboratories, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Twist Bioscience	$312.97M	8.30	-$208.73M	-$3.38	-12.88
Dr. Reddy's Laboratories	$3.35B	3.32	$668M	$0.63	21.20

Does the MarketBeat Community believe in TWST or RDY?

Dr. Reddy's Laboratories received 218 more outperform votes than Twist Bioscience when rated by MarketBeat users. Likewise, 59.33% of users gave Dr. Reddy's Laboratories an outperform vote while only 59.20% of users gave Twist Bioscience an outperform vote.

Company	Underperform	Outperform
Twist Bioscience	Outperform Votes 103 59.20%	Underperform Votes 71 40.80%
Dr. Reddy's Laboratories	Outperform Votes 321 59.33%	Underperform Votes 220 40.67%

Summary

Dr. Reddy's Laboratories beats Twist Bioscience on 12 of the 18 factors compared between the two stocks.